FDA Could Make Generics Liable Amid Push To Undo Mensing
Recent public outcry over the U.S. Supreme Court's decision in Pliva v. Mensing to shield generic-drug makers from product liability suits could push the U.S. Food and Drug Administration to enact regulations that...To view the full article, register now.
Already a subscriber? Click here to view full article